首页> 外文期刊>Biology Open >Ubiquitin A-52 residue ribosomal protein fusion product 1 (Uba52) is essential for preimplantation embryo development
【24h】

Ubiquitin A-52 residue ribosomal protein fusion product 1 (Uba52) is essential for preimplantation embryo development

机译:泛素A-52残留核糖体蛋白融合产物1(Uba52)对植入前胚胎发育至关重要

获取原文
       

摘要

Ubiquitin A-52 residue ribosomal protein fusion product 1(Uba52), a ubiquitin-ribosomal fusion gene, is a major source of ubiquitin protein for covalent modification of proteinaceous substrates recycled by ubiquitin-proteasome system (UPS). Its role in early embryo development has not been studied. Using the CRISPR/Cas9 gene editing tool, the objective of this study was to determine if UBA52 protein is required for mammalian embryogenesis. Matured metaphase II porcine oocytes were injected with CRISPR Cas9+guide RNAs (Uba52 gRNA) or Cas9 without gRNAs as control, followed byin vitrofertilization (IVF) and embryo culture to day?7. Injection of Cas9+gRNAs affected embryo development. On day?4 of embryo culture, the proportion of 2-, 4- and 8-cell stage embryos was significantly different between the Uba52 gRNA and control group (P0.05), with more 8-cell stage embryos in the control and more 4- and 2-cell stage embryos in the Uba52g RNA group. This delay in the development of Uba52 gRNA embryos occurred at the transition from the 4- to 8-cell stages, around the time of major zygotic genomic activation. The percentage of blastocyst formation on day?7 and the cell number per blastocyst were significantly lower in the Uba52 gRNA group than in the control (P0.05). Genotyping by PCR and DNA gel electrophoresis analysis showed that 91.8% of embryos that failed to develop to blastocyst had either a monoallelic or a biallelic modification of theUba52gene. In comparison, only 24.4% of embryos that reached blastocyst had a monoallelic modification and biallelic editing was not found in any of the blastocysts. Based on immuno-labeling intensity, both UBA52 and proteasome protein levels on days?4 and 7 of culture were significantly lower in the Uba52 gRNA group than in the control (P0.05), in agreement with UBA52 western blotting-densitometry of day?4 embryos. Morphological examination of blastomere nuclei revealed abnormal nuclear structure in the Uba52 gRNA group, such as reduced size, irregular shapes, nucleus fragmentation and uneven DNA distribution at all stages of embryo development. Nuclear morphology studies of embryos injected with Cas9+gRNAs and co-injected with plasmid DNA encoding nuclear localized GFP further supported these observations. In conclusion, our data indicate that theUba52gene is essential in early embryogenesis.
机译:泛素A-52残留核糖体蛋白融合产物1(Uba52)是泛素-核糖体融合基因,是泛素蛋白的主要来源,用于对由泛素-蛋白酶体系统(UPS)回收的蛋白质底物进行共价修饰。尚未研究其在早期胚胎发育中的作用。使用CRISPR / Cas9基因编辑工具,本研究的目的是确定哺乳动物胚胎发生是否需要UBA52蛋白。在成熟的中期II猪卵母细胞中注射CRISPR Cas9 + guide RNA(Uba52 gRNA)或没有gRNA的Cas9作为对照,然后进行体外受精(IVF)和胚胎培养至第7天。注射Cas9 + gRNA会影响胚胎发育。在胚胎培养的第4天,Uba52 gRNA与对照组之间的2、4和8细胞期胚胎比例显着不同(P <0.05),对照组中有更多的8细胞期胚胎,更多Uba52g RNA组中的4细胞和2细胞阶段胚胎。 Uba52 gRNA胚胎发育的这种延迟发生在从4细胞到8细胞阶段的过渡期,大约在主要合子基因组激活的时间。 Uba52 gRNA组第7天的胚泡形成百分比和每个胚泡细胞数均明显低于对照组(P <0.05)。通过PCR和DNA凝胶电泳进行的基因分型显示,有91.8%未能发育为胚泡的胚胎具有Uba52基因的单等位基因或双等位基因修饰。相比之下,仅24.4%到达胚泡的胚胎具有单等位基因修饰,并且在任何胚泡中均未发现双等位基因编辑。根据免疫标记强度,在培养的第4天和第7天,UBA52 gRNA组的UBA52和蛋白酶体蛋白水平均显着低于对照组(P <0.05),这与UBA52 Western blot-densitenometry一致。 4个胚胎。卵裂球核的形态学检查显示,Uba52 gRNA组的核结构异常,例如在胚胎发育的各个阶段,大小减小,形状不规则,核碎裂和DNA分布不均匀。注射Cas9 + gRNA并与编码核定位GFP的质粒DNA共注射的胚胎的核形态学研究进一步支持了这些观察结果。总之,我们的数据表明,Uba52基因在早期胚胎发生中必不可少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号